胸主动脉腔内修复术中腹腔干覆盖与保留对临床结局的影响
基于血管质量倡议数据库,回顾性分析25,549例胸主动脉腔内修复(TEVAR)患者中772例远端锚定于6区的病例,比较腹腔干(CA)覆盖且未保留血流(212例)与保留血流(560例)的结局。结果显示,未保留CA血流者30天死亡率(11.3% vs 5.9%;P=0.010)及疾病/治疗相关死亡率(8.0% vs 4.3%;P=0.039)显著更高,校正后30天总死亡风险逾两倍(OR 2.83;95%CI 1.35-5.92;P=0.006),该差异仅见于动脉瘤亚组。
要点
- TEVAR远端锚定于6区时,未保留CA血流的30天死亡率为11.3%,保留CA血流者为5.9%(P=0.010)。
- 未保留CA血流与30天总死亡风险升高相关(OR 2.83;95%CI 1.35-5.92;P=0.006)。
- 该关联仅见于动脉瘤亚组,夹层亚组无显著关联(30天死亡OR 1.16;95%CI 0.22-6.05;P=0.856)。
核心结论
- TEVAR术中覆盖CA且未保留其血流与动脉瘤患者显著更高的死亡率相关,但与夹层患者死亡率无显著关联。
- 作者认为,动脉瘤患者TEVAR术中应尽可能保留CA血流,而夹层患者覆盖CA且不保留血流可能是安全的。
- 作者建议开展前瞻性研究以确认这些发现,并比较开放与腔内血运重建技术对结局的影响。
研究设计与样本
- 基于多机构国家数据库(血管质量倡议)的回顾性队列研究,纳入所有远端锚定于6区的TEVAR患者。
- 共回顾25,549例患者,其中772例远端锚定于6区;212例(27.5%)未保留CA血流,560例(72.5%)保留CA血流。
- TEVAR指征为动脉瘤431例(55.8%)、夹层247例(32.0%)、其他94例(12.2%)。
- 比较两组人口学、临床及围术期特征,以及术后死亡、并发症,并行单因素和多因素回归分析。
主要发现
- 未保留CA血流组30天死亡率为11.3%,保留CA血流组为5.9%(P=0.010)。
- 未保留CA血流组30天疾病/治疗相关死亡率为8.0%,保留CA血流组为4.3%(P=0.039)。
- 未保留CA血流组需干预的肠缺血发生率为1.9%,保留CA血流组为0.5%(P=0.077)。
- 校正混杂因素后,未保留CA血流与30天总死亡风险升高相关(OR 2.83;95%CI 1.35-5.92;P=0.006),与30天疾病/治疗相关死亡风险升高相关(OR 2.72;95%CI 1.11-6.72;P=0.029)。
- 亚组分析中,动脉瘤组上述关联持续存在:30天死亡OR 2.36(95%CI 1.01-5.48;P=0.047),30天疾病/治疗相关死亡OR 2.88(95%CI 1.08-7.67;P=0.034);夹层组无显著关联:30天死亡OR 1.16(95%CI 0.22-6.05;P=0.856),30天疾病/治疗相关死亡OR 0.90(95%CI 0.16-5.19;P=0.911)。
关键数值与推荐
- TEVAR远端锚定于6区且未保留CA血流者,30天死亡风险为保留CA血流者的2.83倍(OR 2.83;95%CI 1.35-5.92;P=0.006)。
- 动脉瘤亚组中,未保留CA血流者30天死亡风险为保留者的2.36倍(OR 2.36;95%CI 1.01-5.48;P=0.047)。
- 夹层亚组中,CA血流保留状态与30天死亡无显著关联(OR 1.16;95%CI 0.22-6.05;P=0.856)。
临床怎么用
- 作者认为,动脉瘤患者行TEVAR时,只要可行应保留CA血流。
- 作者认为,夹层患者行TEVAR时,覆盖CA且不保留其血流可能是安全的。
- 作者建议开展前瞻性研究确认上述发现,并比较开放与腔内血运重建技术对结局的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Adequate proximal and distal seal zones are necessary for successful thoracic endovascular aortic repair (TEVAR). Often, the achievement of an adequate distal seal zone requires celiac artery (CA) coverage by endograft with or without preservation of CA blood flow. The outcomes of CA coverage without its flow preservation were studied only in small case series. This study aims to determine the difference in outcomes between CA coverage with vs without preservation of CA blood flow during TEVAR using a multi-institutional national database. METHODS: The Vascular Quality Initiative database was reviewed for all TEVAR patients distally landing in zone 6. The cohort was divided into TEVAR with vs without CA flow preservation. Demographic, clinical, and perioperative characteristics, as well as postoperative mortality, morbidities, and complications, were compared between the groups. Univariate and multivariate regression analyses were performed. RESULTS: Of 25,549 reviewed patients, 772 had a distal landing in Zone 6, 212 of which (27.5%) had TEVAR without CA flow preservation, whereas 560 (72.5%) underwent TEVAR with CA flow preservation. Indications for TEVAR were aneurysm in 431 (55.8%), dissection in 247 (32.0%), or other in 94 (12.2%) cases. Patients who underwent TEVAR without CA flow preservation had statistically significantly higher rates of 30-day mortality (11.3% vs 5.9%; P = .010), 30-day disease/treatment-related mortality (8.0% vs 4.3%; P = .039), as well as a tendency of increased intestinal ischemia requiring intervention (1.9% vs 0.5%; P = .077). After adjusting for potential confounders, CA coverage without flow preservation was associated with more than a two-fold increase in the overall 30-day mortality (odds ratio [OR], 2.83; 95% confidence interval [CI], 1.35-5.92; P = .006) and 30-day disease/treatment-related mortality (OR, 2.72; 95% CI, 1.11-6.72; P = .029). In a sub-group analysis based on disease pathology, these results persisted only in the aneurysm group (30-day mortality [OR, 2.36; 95% CI, 1.01-5.48; P = .047]; 30-day disease/treatment-related mortality [OR, 2.88; 95% CI, 1.08-7.67; P = .034]), whereas there was no significant association between CA flow preservation status and the endpoints in the dissection subgroup (30-day mortality [OR, 1.16; 95% CI, 0.22-6.05; P = .856], 30-day disease/treatment-related mortality [OR, 0.90; 95% CI, 0.16-5.19; P = .911]). CONCLUSIONS: CA coverage during TEVAR without preservation of its blood flow is associated with significantly higher mortality in patients with aortic aneurysm, but not dissection. In patients with aortic aneurysm, CA flow should be preserved during TEVAR whenever feasible, whereas in patients with dissection, it may be safe to cover CA without preservation of its flow. Prospective studies should be done to confirm these findings and compare the open vs endovascular revascularization techniques on outcomes.
引用
- Veranyan N, Willie-Permor D, Zarrintan S, et al. Clinical outcomes of celiac artery coverage vs preservation during thoracic endovascular aortic repair. J Vasc Surg. 2024. PMID: 38986961. doi:10.1016/j.jvs.2024.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。